Latest Breaking News On - Virpax pharmaceuticals - Page 1 : vimarsana.com

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-diego
California
United-states
Geraldw-bruce
International-convention
Twitter
Department-of-defense
Molecular-envelope-technology
Youtube
National-institutes-of-health
Pharmaceuticals-inc

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Up 907.6% in May

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 79,600 shares, an increase of 907.6% from the April 30th total of 7,900 shares. Based on an average daily trading volume, of 90,300 shares, the days-to-cover […]

Virpax-pharmaceuticals-company-profile
Nasdaq
News-ratings-for-virpax-pharmaceuticals-daily
Virpax-pharmaceuticals-inc
Virpax-pharmaceuticals-price-performance
Virpax-pharmaceuticals
Maxim-group
Get-free-report
Virpax-pharmaceuticals-daily

Maxim Group Reiterates "Hold" Rating for Virpax Pharmaceuticals (NASDAQ:VRPX)

Maxim Group reissued their hold rating on shares of Virpax Pharmaceuticals (NASDAQ:VRPX – Free Report) in a research note released on Wednesday morning, Marketbeat.com reports. Virpax Pharmaceuticals Stock Performance VRPX stock opened at $0.72 on Wednesday. Virpax Pharmaceuticals has a 1-year low of $0.63 and a 1-year high of $11.77. The business’s 50 day moving […]

Virpax-pharmaceuticals-inc
Virpax-pharmaceuticals-stock-performance
Virpax-pharmaceuticals-company-profile
Virpax-pharmaceuticals
Maxim-group
News-ratings-for-virpax-pharmaceuticals-daily
Free-report
Get-free-report
Virpax-pharmaceuticals-daily

Maxim Group Reaffirms "Hold" Rating for Virpax Pharmaceuticals (NASDAQ:VRPX)

Maxim Group reiterated their hold rating on shares of Virpax Pharmaceuticals (NASDAQ:VRPX – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. Virpax Pharmaceuticals Price Performance Shares of VRPX opened at $0.72 on Wednesday. The business’s 50 day simple moving average is $2.96 and its 200-day simple moving average is […]

Virpax-pharmaceuticals-price-performance
Virpax-pharmaceuticals
Maxim-group
News-ratings-for-virpax-pharmaceuticals-daily
Virpax-pharmaceuticals-inc
Free-report
Marketbeat-ratings
Get-free-report
Virpax-pharmaceuticals-daily

Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?

Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Virpax-pharmaceuticals